Abdominal Stent Graft System Market Size (2024 - 2029)

The abdominal stent graft system market is projected to experience growth due to several key factors, including the increasing prevalence of abdominal aortic aneurysms and a rising geriatric population, both of which contribute to a higher demand for these systems. The market size is further influenced by technological advancements in stent design and a growing adoption of minimally invasive surgical procedures. Despite these growth drivers, challenges such as the high cost of surgery and limited long-term benefits may restrain market expansion.

Market Size of Abdominal Stent Graft System Industry

Abdominal Stent Graft System Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 4.10 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Abdominal Stent Graft System Market Major Players

*Disclaimer: Major Players sorted in no particular order

Abdominal Stent Graft System Market Analysis

The abdominal stent graft system market is expected to register a CAGR of 4.1% during the forecast period.

  • COVID-19 significantly impacted the abdominal stent graft system market during the initial wave since COVID-19 patients with aortic aneurysms faced an increased risk of disease complications. For instance, as per the article published in January 2022 in PubMed, COVID-19 infection may cause abdominal aortic aneurysm (AAA) degeneration in many ways. Several processes associated with COVID-19 infection, including higher levels of inflammatory cytokines, have the potential to activate metalloproteinases capable of digesting collagen and elastin, leading to AAA wall degradation.
  • Hence, as COVID-19 patients with AAA were at risk of complications, the demand for the abdominal stent graft system increased during the pandemic. In the post-pandemic era, the market is estimated to witness growth in the future due to the increase in cases of AAA and the rise in the risk of occlusive atherosclerotic disease among the population worldwide.
  • The major factors attributing to the growth of the abdominal stent graft system market are the increasing prevalence of abdominal aortic aneurysms, the rise in the population prone to the risk of occlusive atherosclerosis disease, and the increasing adoption of minimally invasive surgeries. Also rise in the geriatric population is one of the major reasons for the adoption of the abdominal stent graft system market. For instance, as per the Abdominal aortic aneurysm screening: standards report 2021 to 2022 published by the Government of the UK, approximately 274,800 men were offered screening, with 79.0% receiving a conclusive screen during the period of 1st April 2021 to 31 March 2022, in which 1,794 aneurysms (aorta measuring more than or equal to 3.0cm) were found. Thus increase in aneurysm cases is expected to drive market growth over the forecast period.
  • Furthermore, as per the World Population Prospectus 2022 update, the percentage of the population of people aged 65 years or over in the world was estimated to be 9.7 in 2022, and the percentage is expected to rise to 16.4 by 2050. Since the geriatric population is more prone to affecting occlusive atherosclerotic disease, which leads to the adoption of abdominal stent grafts, the rise in the geriatric population bolsters the market growth over the forecast period.
  • Moreover, the technological advancements in stents, increasing adoption of MIS procedures, and presence of competitors are expected to increase the availability of the abdominal stent graft system, leading to market growth. For instance, in May 2021, Endologix launched an implant of its Alto abdominal stent graft in Canada following approval from Health Canada. Alto was also approved for commercial sale in Argentina.
  • The alto abdominal stent graft system is the latest generation in polymer-based therapies for abdominal aortic aneurysm (AAA) patients. The device utilizes a low-profile delivery system and, unlike standard endovascular aneurysm repair (EVAR) devices, features an exclusive conformable sealing ring that molds in situ to the patient's specific aortic neck anatomy.
  • Thus, considering the high prevalence of abdominal aortic aneurysms, the rise in the geriatric population, the technological advancements in stents, and the increasing adoption of MIS procedures, the studied market is expected to witness significant growth over the forecast period. However, the high cost of surgery and lack of long-term benefits are expected to restrain the market growth over the forecast period.

Abdominal Stent Graft System Industry Segmentation

As per the scope of the report, the abdominal stent graft system is used to repair a weakened and bulging part of the aorta, which is the largest part of the abdomen, below the renal arteries. The system comprises an implant, extension implants, and a catheter. The abdominal stent graft system is majorly used in the treatment of abdominal aortic aneurysms (AAA). 

The abdominal stent graft system market is segmented by type (metal stent and polymer stent), end-user (hospitals, ambulatory surgical centers, and other end-users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. 

The report offers the value (in USD million) for the above segments.

By Type
Metal Stent
Polymer Stent
By End-User
Hospitals
Ambulatory Surgical Centers
Other End-Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Abdominal Stent Graft System Market Size Summary

The abdominal stent graft system market is poised for growth, driven by the increasing prevalence of abdominal aortic aneurysms (AAA) and the rising geriatric population, which is more susceptible to occlusive atherosclerotic diseases. The market experienced a surge in demand during the COVID-19 pandemic, as patients with aortic aneurysms faced heightened risks, prompting greater adoption of these systems. Technological advancements in stent designs and the growing preference for minimally invasive surgeries are further propelling market expansion. The introduction of innovative products, such as Endologix's Alto abdominal stent graft, underscores the industry's commitment to enhancing patient outcomes through advanced medical technologies. Despite the promising growth trajectory, challenges such as high surgical costs and limited long-term benefits may temper market expansion.

The hospital segment is expected to see significant growth, fueled by an increase in healthcare facilities offering abdominal stent graft system treatments and a growing pool of skilled professionals. The market's competitive landscape is characterized by strategic initiatives from key players like Endologix, Sofmedica, and Terumo Corporation, who are actively pursuing mergers, acquisitions, and product launches to enhance global availability. North America is anticipated to maintain a substantial market share, supported by a high incidence of AAA, obesity, and hypertension, alongside a robust geriatric demographic. The region's market growth is further bolstered by ongoing clinical studies and research funding aimed at advancing stent graft technologies.

Explore More

Abdominal Stent Graft System Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Prevalence of Abdominal Aortic Aneurysm

      2. 1.2.2 Increase in the Geriatric Population and Risk of Occlusive Atherosclerotic Disease

      3. 1.2.3 Technological Advancements in Stents & Increasing Adoption of MIS Procedures

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Surgery and Treatment

      2. 1.3.2 Lack of Long Term Outcome Benefits

    4. 1.4 Porters Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 2.1 By Type

      1. 2.1.1 Metal Stent

      2. 2.1.2 Polymer Stent

    2. 2.2 By End-User

      1. 2.2.1 Hospitals

      2. 2.2.2 Ambulatory Surgical Centers

      3. 2.2.3 Other End-Users

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Abdominal Stent Graft System Market Size FAQs

The Abdominal Stent Graft System Market is projected to register a CAGR of 4.10% during the forecast period (2024-2029)

Endologix, Inc , Sofmedica, Terumo Corporation, Artivion, Inc and Cook Group are the major companies operating in the Abdominal Stent Graft System Market.

Abdominal Stent Graft System Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)